Literature DB >> 27339088

Low-dose bath with volumetric modulated arc therapy in breast cancer: "Much ado about nothing?".

Filippo Alongi1, Niccolò Giaj-Levra1, Alba Fiorentino1, Rosario Mazzola1, Sergio Fersino1, Francesco Ricchetti1, Ruggero Ruggieri1.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 27339088     DOI: 10.5301/tj.5000516

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916            Impact factor:   2.098


× No keyword cloud information.
  5 in total

1.  Dosimetric comparison of incidental axillary irradiation between three-dimensional conformal and volumetric modulated arc techniques for breast cancer.

Authors:  In Young Jo; Eun Seog Kim; Woo Chul Kim; Chul Kee Min; Seung-Gu Yeo
Journal:  Mol Clin Oncol       Date:  2020-03-30

2.  Three-dimensional conformal versus intensity modulated radiotherapy in breast cancer treatment: is necessary a medical reversal?

Authors:  Alba Fiorentino; Ruggero Ruggieri; Niccolò Giaj-Levra; Gianluisa Sicignano; Gioacchino Di Paola; Stefania Naccarato; Sergio Fersino; Rosario Mazzola; Umberto Tebano; Francesco Ricchetti; Filippo Alongi
Journal:  Radiol Med       Date:  2016-10-24       Impact factor: 3.469

3.  Synchronous bilateral breast cancer irradiation: clinical and dosimetrical issues using volumetric modulated arc therapy and simultaneous integrated boost.

Authors:  Alba Fiorentino; Rosario Mazzola; Stefania Naccarato; Niccolò Giaj-Levra; Sergio Fersino; Gianluisa Sicignano; Umberto Tebano; Francesco Ricchetti; Ruggero Ruggieri; Filippo Alongi
Journal:  Radiol Med       Date:  2017-02-21       Impact factor: 3.469

4.  VMAT radiation-induced nausea and vomiting in adjuvant breast cancer radiotherapy: The incidental effect of low-dose bath exposure.

Authors:  G Lazzari; A Terlizzi; M G Leo; G Silvano
Journal:  Clin Transl Radiat Oncol       Date:  2017-11-06

5.  Effect of Synchronous Versus Sequential Regimens on the Pharmacokinetics and Biodistribution of Regorafenib with Irradiation.

Authors:  Tung-Hu Tsai; Yu-Jen Chen; Li-Ying Wang; Chen-Hsi Hsieh
Journal:  Pharmaceutics       Date:  2021-03-13       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.